$Ocugen (OCGN.US)$ According to industry sources, Covaxin ha...
$Ocugen(OCGN.US$ According to industry sources, Covaxin has been receving good reviews in the US by experts, especially after a remark by White House chief medical adviser Anthony Fauci that Covaxin can neutralise the B1617 variant of coronavirus.Citing a study by ICMR-National Institute of Virology, Ocugen, on Monday, said that Covaxin “demonstrated potential effectiveness against the Brazil variant of SARS-CoV-2.”.“As previously disclosed, a study conducted by ICMR also suggested that Covaxin was effective against the UK variant, as well as the Indian double-mutant variant,” it said.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
